EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reduced FRG1 expression promotes angiogenesis via activation of the FGF2 ‐mediated ERK / AKT pathway

Bratati Mukherjee iD, Pratush Brahma, Talina Mohapatra, Saurabh Chawla, Manjusha Dixit iD

FEBS Open Bio · 2023

DOI: 10.1002/2211-5463.13582 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FEBS Open Bio, 2023. Verfasst von Bratati Mukherjee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cancer and Angiogenesis Research Lab, School of Biological Sciences, National Institute of Science Education and Research, Bhubaneswar, India. Hauptthemen laut MEDLINE: Fibroblast Growth Factor 2, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Atomic Energy, Government of India, National Institute of Science Education and Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Identifying novel targets that control both tumorigenesis and angiogenesis can aid in developing a more potent anti‐angiogenic therapeutic strategy. We previously reported that reduction of FRG1 is associated with increased p38‐MAPK signaling in prostate cancer and with elevated MEK–ERK signaling in breast cancer. Here, we reveal the role of FRG1 in tumor angiogenesis. Our findings demonstrate that depleted FRG1 levels enhance the proliferation, migration, and tubule formation of HUVECs in a paracrine manner, and this was further substantiated in multiple animal models. Mechanistically, FRG1 depletion activated the expression of FGF2 in breast cancer cells, which triggered the ERK/AKT cascade in endothelial cells. As FRG1 affects multiple tumorigenic properties and it is upstream of FGF2, it can be explored as a therapeutic target that is less prone to resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fibroblast Growth Factor 2Proto-Oncogene Proteins c-aktAnimalsMaleCarcinogenesisEndothelial CellsMAP Kinase Signaling SystemSignal TransductionRNA-Binding ProteinsMicrofilament Proteins

Stichwörter der Autor:innen

ERK/AKT signalingFGF2FRG1HUVECsangiogenesisbreast cancer

Substanzen

Fibroblast Growth Factor 2Proto-Oncogene Proteins c-aktRNA-Binding ProteinsMicrofilament Proteins

Autor:innen und Institutionen

  • Cancer and Angiogenesis Research Lab, School of Biological Sciences, National Institute of Science Education and Research, Bhubaneswar, India.
  • Training School Complex, Homi Bhabha National Institute, Anushaktinagar, India.

ORCID-Profile: Bratati Mukherjee, Manjusha Dixit

Förderung

  • Department of Atomic Energy, Government of India
  • National Institute of Science Education and Research

Zitieren

APA

Mukherjee, B., Brahma, P., Mohapatra, T., Chawla, S., & Dixit, M. (2023). Reduced FRG1 expression promotes angiogenesis via activation of the FGF2 ‐mediated ERK / AKT pathway. FEBS Open Bio. https://doi.org/10.1002/2211-5463.13582

Vancouver

Mukherjee B, Brahma P, Mohapatra T, Chawla S, Dixit M. Reduced FRG1 expression promotes angiogenesis via activation of the FGF2 ‐mediated ERK / AKT pathway. FEBS Open Bio. 2023. doi:10.1002/2211-5463.13582

BibTeX
@article{Mukherjee2023,
  author = {Mukherjee, Bratati and Brahma, Pratush and Mohapatra, Talina and Chawla, Saurabh and Dixit, Manjusha},
  title = {Reduced FRG1 expression promotes angiogenesis via activation of the FGF2 ‐mediated ERK / AKT pathway},
  journal = {FEBS Open Bio},
  year = {2023},
  doi = {10.1002/2211-5463.13582}
}
Kostenlos starten →